Gilead sues Teva over HIV med

Gilead Sciences filed a patent infringement lawsuit against Teva Pharmaceutical Industries over the generic drugmaker's move to make a version of the blockbuster HIV treatment Truvada. Release l Report

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.